And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to catch up on our reading, promenade our official mascot, hang with our short people, and take a long leisurely drive through barren back roads. And what about you? This is a lovely time to enjoy the great outdoors. You could get around to that spring cleaning you postponed or make time for someone special. If you feel brave enough, you could also calculate how much those tariffs will cost you. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon. …

Two Democratic lawmakers asked the Department of Health and Human Services to provide documents concerning government patents held on the Truvada HIV prevention pill sold by Gilead Sciences (GILD), as well as documents relating to an agreement reached with the drug maker to donate its medicine. The request was just after the House Committee on Oversight and Government Reform held a hearing to explore the role the government played in discovering Truvada and the high cost of the medicine.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy